iso-sulfan blue has been researched along with technetium tc 99m pentetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Averbook, BJ; Christman, L; Faries, MB; Kim, J; King, DW; Leong, SP; Martinez, SR; Messina, JL; Puleo, CA; Schneebaum, S; Sondak, VK; Wallace, AM; Zager, JS | 1 |
| Proudfoot, J; Unkart, JT; Wallace, AM | 1 |
1 trial(s) available for iso-sulfan blue and technetium tc 99m pentetate
| Article | Year |
|---|---|
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma.
Topics: Adult; Aged; Aged, 80 and over; Coloring Agents; Dextrans; Female; Follow-Up Studies; Humans; Intraoperative Care; Lymph Nodes; Lymphatic Metastasis; Male; Mannans; Melanoma; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Neoplasms; Technetium Tc 99m Pentetate; Young Adult | 2013 |
1 other study(ies) available for iso-sulfan blue and technetium tc 99m pentetate
| Article | Year |
|---|---|
Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
Topics: Aged; Breast Neoplasms; Dextrans; Female; Humans; Injections; Lymphatic Metastasis; Mannans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium Tc 99m Pentetate | 2018 |